• About us
  • Privacy Policy
  • Contact us
Neo Science Hub
ADVERTISEMENT
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
        • Dr. G. V. Purnachand
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In
No Result
View All Result
Neo Science Hub
No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Alzheimer’s Biomarkers Found in Other Dementias, Raising Diagnostic Concerns

Rashmi NSH by Rashmi NSH
2 years ago
in Science News, Healthcare & Medicine
0
Alzheimer

A new study led by researchers from the University of Gothenburg has found that certain biomarkers linked to Alzheimer’s disease can also be found in individuals suffering from other types of dementia. This important discovery could complicate how doctors diagnose different forms of dementia, making it a significant issue for patients and healthcare providers alike.

Biomarkers are substances in the body that can indicate the presence of a disease. In this study, researchers focused on two specific proteins: β-amyloid and tau. These proteins are typically associated with Alzheimer’s disease but were also detected in patients diagnosed with other forms of dementia, such as vascular dementia, frontotemporal dementia, and even Parkinson’s disease dementia.

The study involved analyzing cerebrospinal fluid samples from 13,882 individuals who had been clinically diagnosed with dementia. The researchers discovered that 68% of the participants showed abnormal levels of β-amyloid, and these abnormalities were not exclusive to Alzheimer’s patients. This overlap suggests that similar underlying processes may contribute to different types of dementia.

Memory tests were conducted using the Mini-Mental State Examination (MMSE), which showed that scores were most closely related to biomarker levels in individuals diagnosed with Alzheimer’s disease. Notably, women showed higher levels of tau proteins while men had different ratios in late-onset Alzheimer’s disease, indicating possible gender differences in how dementia presents or progresses.

The findings raise questions about how dementia is currently diagnosed. Traditionally, Alzheimer’s disease is identified based on clinical symptoms and the presence of certain biomarkers. However, the appearance of Alzheimer-associated biomarkers in patients with other types of dementia blurs the lines between these diagnoses.

As dementia prevalence continues to rise globally, the ability to accurately diagnose its various forms becomes increasingly crucial. The presence of Alzheimer’s-related biomarkers in non-Alzheimer’s groups complicates treatment decisions and may delay the implementation of appropriate therapies.

The researchers believe that these findings underline the importance of using reliable biomarker tests for evaluating dementia. Improving diagnostic accuracy could lead to earlier identification of Alzheimer’s-related conditions, ultimately enhancing treatment options as disease-modifying therapies become more accessible.

-Rashmi Kumari

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Tumblr (Opens in new window) Tumblr
  • Share on Telegram (Opens in new window) Telegram
  • Email a link to a friend (Opens in new window) Email
Tags: featuredhealthcarenewssciencenews
Rashmi NSH

Rashmi NSH

Other Posts

Bar chart of decreasing bars beside a line-art antibiotic icon

When the Last Antibiotic Fails: ICMR Finds 91 Per Cent Carbapenem Resistance in a Common Hospital Pathogen

November 21, 2026
0
Map of India's east coast with a stylised cyclone and its forecast track

Akvan Turns North and Drops a Category: IMD Now Expects a Severe Cyclone Between Narsapur and Puri, While Andhra’s Own Forecasters Expect Less

November 21, 2026
0

Antalya’s Last Forty-Eight Hours: Two Contradictory Paragraphs on Fossil Fuels, and India’s Line on the Carbon Budget

Disarm, Don’t Kill: CCMB Scientists Find Two Compounds That Stop a Deadly Fungus Turning Invasive

Eighty Per Cent of the Cost: Andhra Pradesh Raises the Stakes in India’s Chip-Subsidy Contest

Before the First Breath: UNEP and WHO Say Hormone-Disrupting Chemicals Reach Us in the Womb

The Morning Eye Closes: NASA Will Switch Off Terra After 27 Years of Watching the Planet

A Status Lost: Measles Is Endemic Again in the United States, Mexico and Bolivia

Next Post
Pre-Eclampsia

A New Wearable Device Promising Health Insights Without Touching the Skin

Subscribe to Us

Latest Articles

Cross-section of a human eye with the optic nerve head highlighted

FDA Orders Eye-Risk Warnings on All GLP-1 Drugs, From Ozempic to Mounjaro

November 12, 2026
11

Delhi’s Diwali, Measured: Firecrackers Drove 71% of Fine Particles, Lead Hit 20 Times the Limit, and the Worst Readings Went Missing

Global Carbon Budget 2026: The World’s Fossil Emissions Dip, India’s Rise 4.4%, and the 1.5 °C Budget Is Nearly Spent

A New Kind of Blood Thinner: FDA Approves Asundexian to Prevent Repeat Strokes

Andhra Pradesh Opens the Door to Small Nuclear Reactors, Robots and Giga-Scale AI Data Centres — With the Details Still to Come

“Off the Charts”: WMO Tells COP31 That 2026 Is Among the Hottest Years on Record as a Record El Niño Builds

  • Advertise
  • Terms and Conditions
  • Privacy Policy
  • Refund Policy
  • Contact
For Feedback : Email Us

Copyrights © 2025 Neo Science Hub

No Result
View All Result
  • Home
  • e-Mag Archives
  • e-Learning
  • Categories
    • Healthcare & Medicine
    • Pharmaceutical & Chemical
    • Automobiles
    • Blogs
      • Anil Trigunayat
      • BOOKmarked
      • Chadha’s Corner
      • Cyber Gyan
      • Raul Over
      • Taste of Tradition
      • Vantage
    • Business Hub
    • Engineering
    • Innovations
    • Life Sciences
    • Space Technology
  • PhotoSynthesis
  • Subscribe Now
  • Contact us
  • Log In

Copyrights © 2025 Neo Science Hub

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist